Enhanced Th2 cell differentiation and allergen-induced airway inflammation in Zfp35-deficient mice. 2009

Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Studies of human asthma and of animal models of allergic airway inflammation revealed a crucial role for Th2 cells in the pathogenesis of allergic asthma. Kruppel-type zinc finger proteins are the largest family of a regulatory transcription factor for cellular development and function. Zinc finger protein (Zfp) 35 is an 18-zinc finger motif-containing Kruppel-type zinc finger protein, while its function remains largely unknown. The aim of this study was to clarify the role of Zfp35 in the pathogenesis of Th2-dependent allergic inflammation, such as allergic asthma. We examined airway eosinophilic inflammation and hyperresponsiveness in two mouse models, which use our newly generated Zfp35-deficient (Zfp35(-/-)) mice and adoptive transfer of cells. In Zfp35(-/-) mice, Th2 cell differentiation, Th2 cytokine production, eosinophilic inflammation, and airway hyperresponsiveness were substantially enhanced. Furthermore, adoptive transfer of Ag-sensitized Zfp35(-/-) CD4 T cells into the asthmatic mice resulted in enhanced airway inflammation and airway hyperresponsiveness. These results indicate that Zfp35 controls Th2 cell differentiation, allergic airway inflammation, and airway hyperresponsiveness in a negative manner. Thus, Zfp35 may control Th2-dependent diseases, such as allergic asthma.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen

Related Publications

Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
January 2003, Journal of immunology (Baltimore, Md. : 1950),
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
April 2001, Journal of immunology (Baltimore, Md. : 1950),
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
May 2010, Phytotherapy research : PTR,
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
December 2002, The EMBO journal,
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
December 2006, The Journal of allergy and clinical immunology,
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
July 2009, Biochemical and biophysical research communications,
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
September 2016, Immunity, inflammation and disease,
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
June 2011, Journal of immunology (Baltimore, Md. : 1950),
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
March 1995, American journal of respiratory cell and molecular biology,
Masayuki Kitajima, and Chiaki Iwamura, and Takako Miki-Hosokawa, and Kenta Shinoda, and Yusuke Endo, and Yukiko Watanabe, and Ryo Shinnakasu, and Hiroyuki Hosokawa, and Kahoko Hashimoto, and Shinichiro Motohashi, and Haruhiko Koseki, and Osamu Ohara, and Masakatsu Yamashita, and Toshinori Nakayama
January 2018, Mediators of inflammation,
Copied contents to your clipboard!